h i g h l i g h t sThe absorption, bioaccumulation, metabolism and internal exposure of OPFRs are reviewed. Inhalation, ingestion and dermal contact are the main OPFRs absorptionpathways for humans. General in vivo and in vitro metabolic pathways of three different types of OPFRs are proposed. DAPs and MAPs are considered as putative biomarkers for the assessment of internal exposure of OPFRs in humans. a r t i c l e i n f o
t r a c tDue to their widespread use, organophosphate flame retardants (OPFRs) are commonly detected in various environmental matrices and have been identified as emerging contaminants. Considering the adverse effects of OPFRs, many researchers have paid their attention on the absorption, bioaccumulation, metabolism and internal exposure processes of OPFRs in animals and humans. In this article, we first review the diverse absorption routes of OPFRs by animals and humans (e.g., inhalation, ingestion, dermal absorption and gill absorption). Bioaccumulation and biomagnification potentials of OPFRs in different types of organisms and food webs are also summarized, based on quite limited available data and results. For metabolism, we review the Phase-I and Phase-II metabolic processes for each type of OPFRs (chlorinated OPFRs, alkyl-OPFRs and aryl-OPFRs) in the animals and humans, as well as toxicokinetic information and putative exposure biomarkers on OPFRs. Finally, we highlight gaps in our knowledge and critical directions for future internal exposure studies of OPFRs in animals and humans.